-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GA+UI/hpq2sDrZFBFNI31KuM3oBeKmsFy2svi1tAcc+v3vcvylwO08WWxKeIbSgi aFLJuH4IwJx0YTwYYhDhiQ== 0000903423-02-000557.txt : 20020906 0000903423-02-000557.hdr.sgml : 20020906 20020906123755 ACCESSION NUMBER: 0000903423-02-000557 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20020827 FILED AS OF DATE: 20020906 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: TULARIK INC CENTRAL INDEX KEY: 0000889057 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943148800 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28397 FILM NUMBER: 02758199 BUSINESS ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 6508257300 MAIL ADDRESS: STREET 1: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 COMPANY DATA: COMPANY CONFORMED NAME: ZURICH CANTONALBANK CENTRAL INDEX KEY: 0001186713 OWNER FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: POSTFACH CITY: ZURICH STATE: V8 ZIP: 8010 BUSINESS PHONE: 01141012923162 MAIL ADDRESS: STREET 1: POST FACH CITY: ZURICH STATE: V8 ZIP: 8010 3 1 cantonalbankf3_9-05.txt U.S. SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 ________________________________________________________________________________ 1. Name and Address of Reporting Person* Zurich Cantonalbank+ - -------------------------------------------------------------------------------- (Last) (First) (Middle) Postfach - -------------------------------------------------------------------------------- (Street) 8010 Zurich, Switzerland - -------------------------------------------------------------------------------- (City) (State) (Zip) ________________________________________________________________________________ 2. Date of Event Requiring Statement (Month/Day/Year) August 27, 2002 ________________________________________________________________________________ 3. IRS Identification Number of Reporting Person, if an Entity (Voluntary) ________________________________________________________________________________ 4. Issuer Name and Ticker or Trading Symbol Tularik Inc. (TLRK) ________________________________________________________________________________ 5. Relationship of Reporting Person to Issuer (Check all applicable) [_] Director [X] 10% Owner [_] Officer (give title below) [_] Other (specify below) ________________________________________________________________________________ 6. If Amendment, Date of Original (Month/Day/Year) ________________________________________________________________________________ 7. Individual or Joint/Group Filing (Check applicable line) [_] Form Filed by One Reporting Person [X] Form Filed by More than One Reporting Person ================================================================================ Table I -- Non-Derivative Securities Beneficially Owned ================================================================================ 3. Ownership Form: 2. Amount of Securities Direct (D) or 1. Title of Security Beneficially Owned Indirect (I) 4. Nature of Indirect Beneficial Ownership (Instr. 4) (Instr. 4) (Instr. 5) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock 11,358,238 I (1) - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 5(b)(v). + Zurich Cantonalbank is reporting on behalf of itself and Pharma Vision AG. (Print of Type Responses) FORM 3 (continued) Table II -- Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ================================================================================ 5. Owner- 3. Title and Amount of Securities ship Underlying Derivative Security Form of 2. Date Exercisable (Instr. 4) Derivative and Expiration Date --------------------------------- 4. Conver- Security: (Month/Day/Year) Amount sion or Direct 6. Nature of ---------------------- or Exercise (D) or Indirect Date Expira- Number Price of Indirect Beneficial 1. Title of Derivative Exer- tion of Derivative (I) Ownership Security (Instr. 4) cisable Date Title Shares Security (Instr. 5) (Instr. 5) - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses: (1) As of August 27, 2002, Zurich Cantonalbank acquired from BZ Group Holding Limited fifty-one percent of the voting stock of Pharma Vision AG, which directly beneficially owns 11,358,238 shares of Tularik Inc. common stock. The principal business address of Pharma Vision AG is Spielhof 3, 8750 Glarus, Switzerland. ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number. Zurich Cantonalbank /s/ C. Pfammatter 9/5/02 - ------------------------------------------------------------------- **Signature of Reporting Person Date By: C. Pfammatter /s/ B. Heusi 9/5/02 - ------------------------------------------------------------------- **Signature of Reporting Person Date By: B. Heusi Pharma Vision AG /s/ Dr. R. Stadler 9/5/02 - ------------------------------------------------------------------- **Signature of Reporting Person Date By: Dr. R. Stadler /s/ M. Meier 9/5/02 - ------------------------------------------------------------------- **Signature of Reporting Person Date By: M. Meier -----END PRIVACY-ENHANCED MESSAGE-----